A detailed history of First Republic Investment Management, Inc. transactions in Repligen Corp stock. As of the latest transaction made, First Republic Investment Management, Inc. holds 2,597 shares of RGEN stock, worth $375,162. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,597
Holding current value
$375,162
% of portfolio
0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 07, 2023

BUY
$138.78 - $176.51 $360,411 - $458,396
2,597 New
2,597 $412,000
Q1 2023

May 11, 2023

SELL
$154.26 - $198.1 $836,397 - $1.07 Million
-5,422 Reduced 39.5%
8,303 $1.4 Million
Q4 2022

Feb 13, 2023

SELL
$162.42 - $220.56 $185,158 - $251,438
-1,140 Reduced 7.67%
13,725 $2.32 Million
Q3 2022

Nov 03, 2022

SELL
$160.42 - $256.21 $144,217 - $230,332
-899 Reduced 5.7%
14,865 $2.78 Million
Q2 2022

Aug 16, 2022

SELL
$140.68 - $188.02 $619,132 - $827,476
-4,401 Reduced 21.82%
15,764 $2.56 Million
Q1 2022

May 16, 2022

SELL
$161.19 - $257.96 $1.1 Million - $1.77 Million
-6,855 Reduced 25.37%
20,165 $3.79 Million
Q4 2021

Feb 09, 2022

SELL
$247.59 - $304.47 $1.06 Million - $1.31 Million
-4,287 Reduced 13.69%
27,020 $7.16 Million
Q3 2021

Nov 12, 2021

BUY
$194.77 - $324.21 $2.99 Million - $4.98 Million
15,357 Added 96.28%
31,307 $9.05 Million
Q2 2021

Aug 16, 2021

BUY
$165.87 - $220.95 $1.04 Million - $1.38 Million
6,243 Added 64.31%
15,950 $3.18 Million
Q1 2021

May 14, 2021

SELL
$180.37 - $226.26 $389,238 - $488,269
-2,158 Reduced 18.19%
9,707 $1.89 Million
Q4 2020

Feb 16, 2021

BUY
$148.08 - $206.57 $721,149 - $1.01 Million
4,870 Added 69.62%
11,865 $2.27 Million
Q3 2020

Nov 12, 2020

BUY
$122.51 - $158.27 $29,402 - $37,984
240 Added 3.55%
6,995 $1.03 Million
Q2 2020

Aug 13, 2020

BUY
$94.33 - $140.48 $637,199 - $948,942
6,755 New
6,755 $835,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.02B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track First Republic Investment Management, Inc. Portfolio

Follow First Republic Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Republic Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Republic Investment Management, Inc. with notifications on news.